Virios Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Virios Therapeutics (NASDAQ:VIRI) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.07. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $1.69, down 79.46% over the last 52-week period.
August 09, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Virios Therapeutics is expected to report an EPS of $-0.07 in its upcoming earnings. The stock has been on a downward trend, losing 79.46% over the past year.
The company's stock has been on a downward trend, losing nearly 80% of its value over the past year. The upcoming earnings report, with an estimated EPS of $-0.07, could potentially influence the stock's performance. However, past performance shows a mixed impact on the share price post-earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100